Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

Clinical trial NCT07172204 · RECRUITING

Trial details

NCT number: NCT07172204
Sponsor: First Affiliated Hospital of Zhejiang University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intensive Chemotherapy Unfit Newly Diagnosed Acute Myeloid Leukemia (AML)Age ≥60

Start date: 2025-09-16
Primary completion: 2027-07-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.